Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...
Κύριοι συγγραφείς: | Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Nature Portfolio
2024-08-01
|
Σειρά: | Communications Biology |
Διαθέσιμο Online: | https://doi.org/10.1038/s42003-024-06659-8 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
ανά: S. De Taeye, κ.ά.
Έκδοση: (2022-12-01) -
A functional spleen contributes to afucosylated IgG in humans
ανά: Iwona Wojcik, κ.ά.
Έκδοση: (2021-12-01) -
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
ανά: Mary Lopez-Perez, κ.ά.
Έκδοση: (2025-01-01) -
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
ανά: Angela I. Schriek, κ.ά.
Έκδοση: (2022-11-01) -
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
ανά: Angela I. Schriek, κ.ά.
Έκδοση: (2022-05-01)